Gastric Cancer Consensus Conference Recommends Helicobacter pylori Screening and Treatment in Asymptomatic Persons From High-Risk Populations to Prevent Gastric Cancer

被引：82

作者：

Talley, Nicholas J. ^{[1
]}

Fock, Kwong Ming ^{[2
]}

Moayyedi, Paul ^{[3
]}

机构：

[1] Dept Internal Med & Div Gastroenterol Hepatol, Mayo Clin, Jacksonville, FL USA

[2] Changi Gen Hosp, Div Gastroenterol, Dept Med, Singapore, Singapore

[3] McMaster Univ Med Ctr, Div Gastroenterol, Hamilton, ON, Canada

来源：

AMERICAN JOURNAL OF GASTROENTEROLOGY | 2008年 / 103卷 / 03期

关键词：

D O I：

10.1111/j.1572-0241.2008.01819.x

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Gastric adenocarcinoma remains a common cause of death worldwide, and there is convincing evidence that this cancer is causally linked to Helicobacter pylori. The first Asian-Pacific Gastric Cancer Consensus brought together leading authorities in the field including the authors, and systematically reviewed all of the available evidence for the role of H. pylori, diet and other risk factors in this malignancy. The consensus conference boldly recommended population-based screening and treatment for H. pylori in particularly high-risk population settings. The evidence for these recommendations is summarized in this report, and the global and U.S. implications are considered. (Am J Gastroenterol 2008;103:510-514).

引用

页码：510 / 514

页数：5

共 30 条

[1] American college of gastroenterology guideline on the management of Helicobacter pylori infection [J].

Chey, William D. ;

Wong, Benjamin C. Y. .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 (08) :1808-1825

[2] Carcinogenesis of Helicobacter pylori [J].

Correa, Pelayo ;

Houghton, Jeanmarie .

GASTROENTEROLOGY, 2007, 133 (02) :659-672

[3]

Eslick GD, 1999, AM J GASTROENTEROL, V94, P2373, DOI 10.1111/j.1572-0241.1999.01360.x

[4] Meta-analysis:: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori [J].

Fischbach, L. ;

Evans, E. L. .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2007, 26 (03) :343-357

[5]

FOCK KM, 2008, J GASTROENT IN PRESS

[6] A community screening program for Helicobacter pylori saves money:: 10-year follow-up of a randomized controlled trial [J].

Ford, AC ;

Forman, D ;

Bailey, AG ;

Axon, ATR ;

Moayyedi, P .

GASTROENTEROLOGY, 2005, 129 (06) :1910-1917

[7] Meta-analysis:: duration of first-line proton-pump inhibitor-based triple therapy for Helicobacter pylori eradication [J].

Fuccio, Lorenzo ;

Minardi, Maria Eugenia ;

Zagari, Rocco Maurizio ;

Grilli, Diego ;

Magrini, Nicola ;

Bazzoli, Franco .

ANNALS OF INTERNAL MEDICINE, 2007, 147 (08) :553-562

[8] Canadian Helicobacter Study Group Consensus Conference:: Update on the management of Helicobacter pylori -: An evidence-based evaluation of six topics relevant to clinical outcomes in patients evaluated for H pylori infection [J].

Hunt, R ;

Fallone, C ;

van Zanten, SV ;

Sherman, P ;

Smaill, F ;

Flook, N ;

Thomson, A .

CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2004, 18 (09) :547-554

[9] Report of the 1997 Asia Pacific Consensus Conference on the Management of Helicobacter pylori Infection [J].

Lam, SJ ;

Talley, NJ .

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1998, 13 (01) :1-12

[10] Factors predicting progression of gastric intestinal metaplasia:: results of a randomised trial on Helicobacter pylori eradication [J].

Leung, WK ;

Lin, SR ;

Ching, JYL ;

To, KF ;

Ng, EKW ;

Chan, FKL ;

Lau, JYW ;

Sung, JJY .

GUT, 2004, 53 (09) :1244-1249

← 1 2 3 →